Atlas Trials

Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-AG-120

Clinical trial NCT02489513 · COMPLETED

Trial details

NCT number
NCT02489513
Sponsor
Agios Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2015-06-01
Primary completion
2015-09-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.